AIMA Laboratories (AIMA), a FemTech company dedicated to developing new products that fill current gaps in gynecological health, will be featured on CHCH Evening News at 6 p.m. (ET).
AIMA will be entering a new partnership with Innovative Health Diagnostics (IHD), a CLIA- and FDA-certified lab that empowers every person access to accurate, clinical testing by providing testing when and where it matters most, to develop and deliver a new and reliable at-home blood test to detect endometriosis.
Endometriosis is a disease where tissue similar to the lining of the uterus grows outside the uterus, causing pain and/or infertility. For the roughly 10% of reproductive-age women and girls globally who have endometriosis – approximately 190 million – there is a significant gap between when symptoms first appear and when they are diagnosed, which can typically take around five to 12 years.
The test being developed identifies certain microRNA biomarkers that are differentially expressed in women with endometriosis compared to women without. The test’s accuracy is comparable to laparoscopy, a type of surgery that is used to get a closer look into a woman’s abdomen and reproductive system. Laparoscopy is used to both diagnose and treat endometriosis, detecting and removing endometrial lesions. Because laparoscopy is a more invasive procedure, it often takes years for women to get tested and treated.
Watch the CHCH broadcast live at 6 p.m. – 7 p.m. (ET): chch.com/live/
CHCH will broadcast the full episode on chch.com/news/evening-news/ (Search for August 31, part 2)